https://hipa.ai/drug/alirocumab/updates/trial-results-posted-nct03537742-2026-08-18 Hipa.ai en 2026-08-18T00:00:00.000Z Alirocumab Trial Posts Plaque-Volume Results After Transplant https://hipa.ai/drug/glofitamab/updates/trial-results-posted-nct04980222-2026-08-18 Hipa.ai en 2026-08-18T00:00:00.000Z Glofitamab trial reports 73.3% complete response rate https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct03173950-2026-08-18 Hipa.ai en 2026-08-18T00:00:00.000Z Nivolumab trial posts results in rare recurrent CNS cancers https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03650764-2026-08-17 Hipa.ai en 2026-08-17T00:00:00.000Z Pembrolizumab Trial in Head and Neck Cancer Posts Results https://hipa.ai/drug/atezolizumab/updates/trial-results-posted-nct03654833-2026-08-17 Hipa.ai en 2026-08-17T00:00:00.000Z Atezolizumab Trial Results Posted in Relapsed Mesothelioma https://hipa.ai/drug/canagliflozin/updates/boxed-warning-present-label-sitagliptin-metformin-2026-08-13 Hipa.ai en 2026-08-13T00:00:00.000Z Canagliflozin Data Record Notes Metformin Boxed Warning https://hipa.ai/drug/tofacitinib/updates/boxed-warning-present-label-tofacitinib-label-effective-2026-2026-08-13 Hipa.ai en 2026-08-13T00:00:00.000Z Tofacitinib Label Carries Boxed Warning for Serious Infections